Keyphrases
Dihydroartemisinin
100%
Artemisinin Derivatives
100%
Wild-type p53
100%
Death Receptor 5
100%
TRAIL-induced Apoptosis
100%
Artesunate
60%
Cancer Cells
40%
Induced Apoptosis
40%
HCT116
40%
DLD-1 Cells
40%
Cell Death
20%
Artemisinin
20%
DNA-binding Domain
20%
Novel Therapies
20%
Colon Cancer
20%
Colon Cancer Cells
20%
Cancer Spheroids
20%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
20%
Overcoming Resistance
20%
Combination Treatment
20%
Cervical Cancer Cells
20%
P53 DNA Binding
20%
TRAIL Resistance
20%
Liver Cancer Stem Cells
20%
Anti-malaria Drugs
20%
Knockdown Assay
20%
HCT116 Cells
20%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Death Receptor 5
100%
Artemisinin Derivative
100%
Dihydroartemisinin
83%
Artesunate
50%
Malignant Neoplasm
33%
Colon Cancer
33%
Uterine Cervix Cancer
16%
Liver Cancer
16%
Artemisinin
16%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
16%
Antimalarial Agent
16%
Biochemistry, Genetics and Molecular Biology
Eicosanoid Receptor
100%
P53
100%
TRAIL
100%
Cancer Cell
66%
Colon
33%
Cell Death
16%
Tumor Spheroid
16%
DNA-binding Domain
16%
Tumor Necrosis Factor
16%